Home > Boards > US Listed > Biotechs > Ekso Bionics Holdings, Inc. (EKSO)

In my opinion the company is still undervalued.

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
JohnathanSpr Member Profile
 
Followed By 0
Posts 10
Boards Moderated 0
Alias Born 08/30/19
160x600 placeholder
Securities Registration Statement (s-1) Edgar (US Regulatory) - 7/2/2020 6:15:58 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/26/2020 4:25:23 PM
Ekso Bionics® Receives FDA Clearance to Market its EksoNR™ Robotic Exoskeleton for Use with Acquired Brain Injury Patients... GlobeNewswire Inc. - 6/25/2020 8:30:10 AM
Statement of Ownership (sc 13g) Edgar (US Regulatory) - 6/18/2020 4:28:47 PM
Securities Registration Statement (simplified Form) (s-3) Edgar (US Regulatory) - 6/16/2020 8:01:47 AM
Amended Current Report Filing (8-k/a) Edgar (US Regulatory) - 6/15/2020 4:20:16 PM
Ekso Bionics Announces Closing of $7.89 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/10/2020 1:30:16 PM
Prospectus Filed Pursuant to Rule 424(b)(5) (424b5) Edgar (US Regulatory) - 6/9/2020 5:14:38 PM
Ekso Bionics Announces $7.89 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules GlobeNewswire Inc. - 6/8/2020 8:00:10 AM
Ekso Bionics® Named “Best Healthcare Robotics Company” in 2020 MedTech Breakthrough Awards Program GlobeNewswire Inc. - 6/3/2020 8:00:10 AM
Ekso Bionics Announces CFIUS Determination Regarding China Joint Venture GlobeNewswire Inc. - 5/20/2020 4:10:10 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 5/15/2020 6:04:02 AM
Quarterly Report (10-q) Edgar (US Regulatory) - 4/30/2020 4:47:07 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/30/2020 4:25:35 PM
Ekso Bionics Reports First Quarter 2020 Results GlobeNewswire Inc. - 4/30/2020 4:05:10 PM
Amended Annual Report (10-k/a) Edgar (US Regulatory) - 4/28/2020 6:09:07 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/24/2020 4:17:26 PM
Ekso Bionics® to Report First Quarter 2020 Financial Results on April 30, 2020 GlobeNewswire Inc. - 4/23/2020 7:30:10 AM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/9/2020 4:27:24 PM
Ekso Bionics Provides COVID-19 Business Update and Reports Preliminary First Quarter 2020 Financial Results GlobeNewswire Inc. - 4/9/2020 4:01:10 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 5:04:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 5:01:35 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:58:01 PM
Statement of Changes in Beneficial Ownership (4) Edgar (US Regulatory) - 4/2/2020 4:55:27 PM
Current Report Filing (8-k) Edgar (US Regulatory) - 4/1/2020 4:23:03 PM
JohnathanSpr   Sunday, 06/28/20 11:38:47 AM
Re: None
Post # of 6463 
In my opinion the company is still undervalued. Steady (but slow) revenue increase, new product and significant decrease in the expenses. Ekso NR is currently the best product on the market, the Vest is still a wild card and lets not forget about the established collaboration with hospitals, universities.
It will be interesting to see how the covid 19 situation disrupted the operations.
I think it will be still undervalued in short term but I dont expect any further share sale/offering in the next 12 months, the Q2 results will give some guidance on the cash burn.

Everyone is critizing Jack and the management, maybe rightfully, but they have a plan and they are going forward.

...my 2 cents

Public Reply | Private Reply | Keep | Last ReadPost New MsgNext 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist